Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Schizophrenia

Free Subscription 09.03.2026 1 Acta Psychiatr Scand 1 Am J Med Genet B Neuropsychiatr Genet 4 Am J Psychiatry 1 Biol Psychiatry 1 Can J Psychiatry 1 PLoS One 1 Proc Natl Acad Sci U S A 3 Psychiatry Res 1 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. TSAI SY, Lee YT, Sajatovic M, Hung S, et al
   Association Between Accelerated Atherosclerosis and High-Sensitivity C-Reactive Protein Levels in Bipolar Disorder and Schizophrenia.
   Acta Psychiatr Scand. 2026 Mar 5. doi: 10.1111/acps.70083.
   PubMed         Abstract available
   
   

   
   Am J Med Genet B Neuropsychiatr Genet

2. LIN CP, Wei LC
   Commentary on Immune-Genomic Approaches to Schizophrenia: Highlighting IRF3, L3HYPDH, and Drug Repurposing Targets.
   Am J Med Genet B Neuropsychiatr Genet. 2026 Mar 2. doi: 10.1002/ajmgb.70009.
   PubMed        
   
   

   
   Am J Psychiatry

3. MARDER SR
   Finding a Medication for Negative Symptoms in Schizophrenia: Why So Many Failures?
   Am J Psychiatry. 2026;183:154-155.
   PubMed        
   
   
4. MYUNG W, Ahn Y, Kim J, Won HH, et al
   Targeted Therapeutic Intervention for Problematic Alcohol Use, Comorbid Depressive Disorder, and Schizophrenia: Response to Lawford and Norrie.
   Am J Psychiatry. 2026;183:216.
   PubMed        
   
   
5. LI C, Sun P
   Overlooked Methodological Limitations in the Study of Grip Strength and Default Mode Network Connectivity in Early Psychosis.
   Am J Psychiatry. 2026;183:214.
   PubMed        
   
   
6. KALIN NH
   Advances Relevant to Treating Bipolar Disorder, PTSD, and Schizophrenia.
   Am J Psychiatry. 2026;183:149-151.
   PubMed        
   
   

   
   Biol Psychiatry

7. HAMILTON HK, Roach BJ, Nicholas S, Dembo R, et al
   Visual P300 and risk for psychosis onset in youth at clinical high-risk.
   Biol Psychiatry. 2026 Feb 28:S0006-3223(26)00090.
   PubMed         Abstract available
   
   

   
   Can J Psychiatry

8. WHITE N, Potvin S, Do A, Stip E, et al
   Cognitive Complaints in Schizophrenia: A Meta-Analysis of Studies Using the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS): Les plaintes cognitives dans la schizophrenie : Une meta-analyse des etudes utilisant la Subjective Scale
   Can J Psychiatry. 2026 Mar 3:7067437261425086. doi: 10.1177/07067437261425086.
   PubMed         Abstract available
   
   

   
   PLoS One

9. HABLA AF, Soleim SB, Due AS, Tinglef TH, et al
   Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study.
   PLoS One. 2026;21:e0333716.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

10. SUNSHINE AB, Gulsuner S, Williams CA, Sarchi M, et al
    Loss of function of the chromatin remodeling gene INO80D leads to neurogenic features of schizophrenia.
    Proc Natl Acad Sci U S A. 2026;123:e2536039123.
    PubMed         Abstract available
    
    

    
    Psychiatry Res

11. BRENUGAT L, Mendy M, Maitre A, Danset C, et al
    Personalized approach to cognitive remediation for people with schizophrenia and autism.
    Psychiatry Res. 2026;359:117054.
    PubMed         Abstract available
    
    
12. SHIZUKAWA K
    Letter to the Editor: Comment regarding "A comparative study of medication adherence in schizophrenia patients receiving clozapine and other antipsychotics".
    Psychiatry Res. 2026;359:117047.
    PubMed        
    
    
13. FUKUMOTO K, Ohi K, Ito S, Yasuda Y, et al
    Psychiatrists' adherence to guideline-recommended pharmacotherapy for schizophrenia affects subcortical structural alterations in the brains of patients with schizophrenia.
    Psychiatry Res. 2026;359:117050.
    PubMed         Abstract available
    
    

    
    Psychol Med

14. PATLOLA SR, Hallahan B, McManus R, Kenyon M, et al
    Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis.
    Psychol Med. 2026;56:e63.
    PubMed         Abstract available
    
    

    
    Schizophr Res

15. DENG W, Servaas MN, Kos C, Marsman JC, et al
    Motor activity-based prediction of the presence of apathy in schizophrenia.
    Schizophr Res. 2026;292:1-11.
    PubMed         Abstract available
    
    
16. SONDERGAARD A, Hemager N, Wilms M, Rohd SB, et al
    Associations between Sleep Problems, Psychotic Experiences and Mental Disorders in Children at Familial High Risk of Schizophrenia or Bipolar Disorder and Population-based controls - The Danish High Risk and Resilience Study.
    Schizophr Res. 2026;291:99-106.
    PubMed         Abstract available
    
    
17. SHI S, Wang J, Li H, Qiu J, et al
    Prevalence of covert cerebrovascular changes in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2026;291:107-118.
    PubMed         Abstract available
    
    
18. ZENG V, Hoang D, Song SH, Trotti R, et al
    Mediodorsal and pulvinar thalamus reductions across the psychosis spectrum.
    Schizophr Res. 2026;291:88-98.
    PubMed         Abstract available
    
    
19. POKORNY VJ, Kaka T, Vargas T, Pinkham AE, et al
    Phantom vibrations: An understudied marker of clinical risk for psychosis.
    Schizophr Res. 2026;291:81-87.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum